ARX — Aroa Biosurgery Cashflow Statement
0.000.00%
Last trade - 00:00- AU$204.80m
- AU$184.26m
- NZ$69.07m
- 76
- 51
- 31
- 54
Annual cashflow statement for Aroa Biosurgery, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.004 | 0.134 | 0.136 | 1.17 | 1.73 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.66 | -5.01 | -11.5 | -3.77 | -7.38 |
| Capital Expenditures | -1.87 | -1.5 | -4.87 | -7.61 | -6.99 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -20 | -30 | 14.9 | 17.1 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -1.87 | -21.5 | -34.9 | 7.25 | 10.1 |
| Financing Cash Flow Items | 5.82 | 15.1 | -2.6 | -0.379 | -0.405 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.384 | 37.1 | 37.6 | -0.504 | -1.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.607 | 11.5 | -9.22 | 3.38 | 1.98 |